LYON, France--(BUSINESS WIRE)--Regulatory News:
ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company developing innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced that Gil Beyen, Chairman and Chief Executive Officer and Eric Soyer, Chief Financial Officer and Chief Operating Officer, will present at the 18th Annual BIO CEO and Investor Conference being held February 8-9, 2016 and the Leerink Partners 5th Annual Global Healthcare Conference being held February 10-11, 2016. Both conferences are being held at the Waldorf Astoria Hotel in New York.
